๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics, pharmacodynamics, and minimum effective clinical dose of intravenous nicardipine

โœ Scribed by Cook, Eileen; Clifton, G Gil; Vargas, Ramon; Bienvenu, Gregory; Williams, Roger; Sambol, Nancy; McMahon, Gil; Grandy, Susan; Lai, Chii-Ming; Quon, Check

Book ID
109844908
Publisher
Nature Publishing Group
Year
1990
Tongue
English
Weight
962 KB
Volume
47
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Single intravenous dose and steady-state
Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects
โœ John G. Wagner; Teck L. Ling; Edward J. Mroszczak; Donna Freedman; Ann Wu; Bee H ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB

Nicardipine HCI oral doses (10-40 mg) were administered sequentially to six healthy subjects. For each regimen the capsule dose was administered every 8 hours (q 8 h) for 3 days and the plasma profiles of nicardipine and its pyridine analogue (M5) were determined following the last dose on day 4. St

Effect of intravenous infusion time on t
Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide
โœ Si H. Ryoo; Myung G. Lee; Min H. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 577 KB

The pharmacokinetics and pharmacodynamics of bumetanide were evaluated after intravenous (i.v.) administration of the same total dose of bumetanide in different lengths of infusion times, 10 s (treatment I), 1 h (treatment 11), and 4 h (treatment 111) to rabbits. The fluid loss in urine was immedia